跳至主要内容
临床试验/NCT01243918
NCT01243918终止不适用

Evaluation of Oxygen Therapy Delivery Systems in Hypoxemic Acute Respiratory Failure

Nantes University Hospital1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2010年11月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
16
试验地点
1
主要终点
Calcul of the ratio PaO2/FiO2

研究概览

简要总结

The main objective of this study is to evaluate the efficiency of the oxygen therapy delivery system Optiflow® compared to 2 others standard oxygen therapy delivery systems (Ospal®, non invasive ventilation).12 immunocompetent patients will compare the successive use of oxygen therapy delivery systems Optiflow®/Ospal® and 12 immunodeficient patients will compare the successive use of systems Optiflow®/Non invasive ventilation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient hospitalized in the intensive care unit of Nantes University Hospital
  • Signed informed consent
  • Patient with not hypercapnic acute hypoxemic respiratory failure
  • Immunocompetent and immunodeficient patient

排除标准

  • Age < 18 years
  • Pregnancy
  • Contra-indication to non invasive ventilation
  • Allergy to xylocaine
  • Coagulation troubles
  • Tracheotomized patient
  • Urgent indication to intubation
  • Hypercapnic acute respiratory failure
  • Acute pulmonary edema
  • Face or nose malformation

结局指标

主要结局

Calcul of the ratio PaO2/FiO2

时间窗: one hour after each system used

The main objective of this study is to evaluate the efficiency of the oxygen therapy delivery system Optiflow® compared to 2 others standard oxygen therapy delivery systems (Ospal®, non invasive ventilation) by calculating the ratio PaO2/FiO2

次要结局

  • number of participants with adverse events
  • measure of respiratory frequency and blood gas
  • measure of positive and expiratory pressure

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验